M. Figueras

582 total citations
18 papers, 476 citations indexed

About

M. Figueras is a scholar working on Cardiology and Cardiovascular Medicine, Economics and Econometrics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, M. Figueras has authored 18 papers receiving a total of 476 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cardiology and Cardiovascular Medicine, 4 papers in Economics and Econometrics and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in M. Figueras's work include Blood Pressure and Hypertension Studies (4 papers), Gastrointestinal motility and disorders (3 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). M. Figueras is often cited by papers focused on Blood Pressure and Hypertension Studies (4 papers), Gastrointestinal motility and disorders (3 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). M. Figueras collaborates with scholars based in Spain, United Kingdom and Qatar. M. Figueras's co-authors include Vicente Gil-Guillén, E. Márquez Contreras, Marc Miravitlles, M Balañá, Nieves Martell Claros, Mariano de la Figuera von Wichmann, Alicia Serra, Marta Comellas, Luís Lizán and Carles Blanch and has published in prestigious journals such as Alimentary Pharmacology & Therapeutics, Quality of Life Research and Journal of Hypertension.

In The Last Decade

M. Figueras

16 papers receiving 443 citations

Peers

M. Figueras

CCM

GHP

GASTR

SURGE

Mats Foldevi Sweden

Asangaedem Akpan United Kingdom

Christopher R. McBurney United States

Helen Crocker United Kingdom

E. Bardelli Italy

Elizabeth Wiley-Exley United States

Gretchen Rickards United States

J. Jones United Kingdom

Karishma Desai United States

Choon How How Singapore

Mats Foldevi Sweden

M. Figueras

62 ×0.4

CCM

135 ×1.1

GHP

15 ×0.2

GASTR

27 ×0.3

180 ×2.1

SURGE

Citations per year, relative to M. Figueras M. Figueras (= 1×) peers Mats Foldevi

Countries citing papers authored by M. Figueras

Since Specialization

Citations

This map shows the geographic impact of M. Figueras's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Figueras with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Figueras more than expected).

Fields of papers citing papers by M. Figueras

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Figueras. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Figueras. The network helps show where M. Figueras may publish in the future.

Co-authorship network of co-authors of M. Figueras

This figure shows the co-authorship network connecting the top 25 collaborators of M. Figueras. A scholar is included among the top collaborators of M. Figueras based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Figueras. M. Figueras is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Figueras, M., et al.. (2016). Cost-Effectiveness Analysis of Sacubitril/Valsartan in Chronic Heart Failure with Reduced Ejection Fraction in Spain. Value in Health. 19(7). A650–A650. 1 indexed citations

Blanch, Carles, et al.. (2016). Health-related quality of life in patients with psoriasis: a systematic review of the European literature. Quality of Life Research. 25(11). 2739–2754. 47 indexed citations

Blanch, Carles, et al.. (2015). Biologic treatments for moderate-severe psoriasis. What efficacy gives you, cost should not take it away. Value in Health. 18(7). A417–A417. 1 indexed citations

Figueras, M., et al.. (2015). Cost-Effectiveness of New Therapies for Multiple Sclerosis In Spain. Value in Health. 18(7). A757–A757. 1 indexed citations

Figueras, M., et al.. (2014). Factors Conditioning Health Related Quality Of Life In Patients With Psoriasis In Europe: A Systematic Review Of The Literature. Value in Health. 17(7). A612–A612. 2 indexed citations

Figueras, M., et al.. (2014). Costs of Psoriasis in Europe. A Systematic Review of the Literature. Value in Health. 17(7). A606–A606. 5 indexed citations

Torres, Carolina Machado, et al.. (2013). Cost-Effectiveness Analysis of Glycopyrronium Bromide in the Treatment of Chronic Obstructive Pulmonary Disease in Spain. Value in Health. 16(7). A372–A372.

Brosa, Max, Mariano de la Figuera, Josep Franch‐Nadal, et al.. (2009). Análisis coste-efectividad de aliskiren en pacientes hipertensos, con diabetes tipo 2 y nefropatía ya tratados de forma óptima con ARA-II y otros fármacos antihipertensivos. 6(3). 91–100.

Garrigues, Vicente, Fermín Mearin, Xavier Badı́a, et al.. (2007). Change over time of bowel habit in irritable bowel syndrome: a prospective, observational, 1‐year follow‐up study (RITMO study). Alimentary Pharmacology & Therapeutics. 25(3). 323–332. 51 indexed citations

10.

Benavent, Jaume, et al.. (2006). Impact of upper digestive symptoms in patients with irritable bowel syndrome. European Journal of Gastroenterology & Hepatology. 18(12). 1271–1277. 21 indexed citations

11.

Mearin, Fermín, Xavier Badı́a, Jaume Benavent, et al.. (2006). Predictive factors of irritable bowel syndrome improvement: 1‐year prospective evaluation in 400 patients. Alimentary Pharmacology & Therapeutics. 23(6). 815–826. 27 indexed citations

12.

Contreras, E. Márquez, et al.. (2005). Efficacy of a home blood pressure monitoring programme on therapeutic compliance in hypertension: the EAPACUM–HTA study. Journal of Hypertension. 24(1). 169–175. 138 indexed citations

13.

Contreras, E. Márquez, et al.. (2004). Eficacia de una intervención informativa a hipertensos mediante mensajes de alerta en el teléfono móvil (HTA-ALERT). Atención Primaria. 34(8). 399–405. 103 indexed citations

14.

Segura, J., et al.. (2003). Resultados de la primera encuesta sobre patrones de uso e interés por las nuevas tecnologías de los pacientes atendidos en Unidades de Hipertensión Arterial en España. Hipertensión y Riesgo Vascular. 20(2). 50–55. 4 indexed citations

15.

Miravitlles, Marc & M. Figueras. (2001). El coste de la enfermedad pulmonar obstructiva crónica en España. Opciones para una optimización de recursos. Archivos de Bronconeumología. 37(9). 388–393. 37 indexed citations

16.

Rovira, Joan, et al.. (2000). Impacto de los estudios de evaluación económica en la toma de decisiones sanitarias en el ámbito hospitalario. 4(11). 171–179. 12 indexed citations

17.

Rovira, Jordi, M. Figueras, & Josefina Caminal. (1999). IR2: THE COSTS OF THE INADEQUATE USE OF ANTIBIOTICS. Value in Health. 2(5). 357–357. 1 indexed citations

18.

Raich, Rosa M., et al.. (1996). Estudio de la imagen corporal y su relación con el deporte en una muestra de estudiantes universitarios. Análisis y Modificación de Conducta. 22(85). 603–626. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact